Ben Comer

Do Big Pharma dollars make physicians lousy caregivers?

In 2012, Merck's diabetes franchise became the highest-selling product family in its 122-year history.

After years of asking questions, the National Highway Traffic Safety Administration (NHTSA)is moving closer to a protocol "for assessing the driving-impairment risks of drugs". Ben Comer reports.

Compliance officers have risen into management's highest ranks, by choice in some organizations, and by government decree in others. Either way, their importance as a strategic partner can hardly be understated.

Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.

Is the 'lost decade' of declining pipeline productivity finally over? Our annual survey of analyst assessments of the state of drug development suggests so...

Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures.

A comparative effectiveness study on the two presidential candidates.

Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. Patient voices are increasing in volume, along with their roles in treatment decisions.